This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
At the annual meeting of the American Academy of Otolaryngology-Head Neck Surgery in Chicago, Richard Mabry, MD, Dallas, discussed the management of turbinate disease and concluded on the basis of clinical observation that patients with nasal obstruction should be treated with conservative therapy first. This may include antihistamines, turbinate injection, allergy management, and/or corticosteroids. He noted that turbinate fracture and cautery have been used, but he does not favor them in his practice. He feels that any reduction in turbinate size ought not to be accompanied by a diminution in the function of this important structure.
Dr Mabry's technique of turbinate reduction involves the removal of the lateral portion of the turbinate, including the turbinal bone, leaving the mucosa medially intact. This will avoid the problems of atrophic rhinitis and consequent dissatisfaction.
In the 61 patients so treated in 1981 and 1982, a survey was conducted in 1986. He received
KIMMELMAN CP. Inferior Turbinoplasty: Patient Selection, Technique, and Long-term Consequences. Arch Otolaryngol Head Neck Surg. 1988;114(6):609. doi:10.1001/archotol.1988.01860180023001
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: